MGH Clinical Trial for Lung Cancer: Targeted Therapies to Halt Tumor Growth

Linnea Duff tells her story about participating in a clinical trial of a potential new targeted treatment drug that has provided powerful evidence that it can halt or reverse the growth of lung tumors characterized by a specific genetic abnormality. In their report in the October 28 New England Journal of Medicine, a multi-institutional research team reports that daily doses of the investigational drug crizotinib shrank the tumors of more than half of a group patients whose tumors were driven by alterations in the anaplastic lymphoma kinase (ALK) gene. In another one-third of study participants, crizotinib treatment suppressed tumor growth.

Fore more information visit: http://www.massgeneral.org/cancer/news/faq.aspx

Press Release: http://www.massgeneral.org/about/pressrelease.aspx?id=1292

Category:

Science & Technology

Tags:

• cancer
• health
• medicine
• science
• technology